Evidence map›Paper›PMID 39561129›Full record

Trial reportPloS one2024

Effectiveness of interactive voice response-call for life mHealth tool on adherence to anti-retroviral therapy among young people living with HIV: A randomized trial in Uganda.

Agnes Bwanika Naggirinya, David B Meya, Maria Sarah Nabaggala, Grace Banturaki, Agnes Kiragga, Joseph Rujumba, Peter Waiswa, Rosalind Parkes-Ratanshi

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04718974 (Acceptability, Effect and Cost of Mobile-health on ART Adherence Among Youths), which is not on this map. Cited by 7 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04718974 nacompletednot on this map

Acceptability, Effect and Cost of Mobile-health on ART Adherence Among Youths: A Mixed Methods Sequential Study in Kiryandongo

TypeinterventionalSponsorMakerere UniversityRan2020 to 2022Enrolled206ConditionsART Adherence, HIV-1-infection, mHealthArmsmHealth call for life system/ tool using IVR ( interactive voice response)
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Agnes Bwanika NaggirinyaDepartment of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.ORCID 0000-0001-8722-4135
David B MeyaDepartment of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.
Maria Sarah NabaggalaInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Grace BanturakiInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Agnes KiraggaInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Joseph RujumbaDepartment of Pediatrics and Child Health, College of Health Sciences, Makerere University, Kampala, Uganda.
Peter WaiswaDivision of Global Health, School of Public Health, College of Health Sciences, Makerere University, Kampala, Uganda.
Rosalind Parkes-RatanshiInfectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn people living with HIV, adherence to antiretroviral therapy (ART) is essential for achieving and sustaining viral suppression and reducing mortality. In young people living with HIV, ART adherence and retention remain a challenge with unsatisfactory viral suppression rates despite facility-based intensive adherence counseling that is the standard of care. Few studies have evaluated mHealth adherence interventions among young people living with HIV in resource-limited settings.

methodsThis was a randomized parallel trial. Young people aged between15-24 living with HIV, initiating ART, or on ART for not more than 6 months at three ART clinics were recruited and randomized to a ratio of 1:1 to either standard of care or the intervention "Call for Life-Interactive Voice Response" with standard of care, between 12th August 2020 and 1st June 2022. The intervention is mobile technology-based software, that has interactive voice response functionalities, with a web-based interface, that allows interaction through the use of voice and tones via a dial pad. The primary outcome was viral suppression defined as HIV RNA below 1,000 copies per mL at 12 months with retention in care and viral suppression at month 6 as a secondary outcome. Descriptive statistics were used for participant characteristics. Primary outcomes and factors associated with viral load failure were assessed using the log-binomial model. All calculations were done using statistical software release 16.0.

resultsA total of 206 participants were recruited and randomized; the mean age was 22.5(SD±1.9) years and 81% (167/206) were female. The intervention had 78.6% (81/103), females, while the standard of care had 83.5% (86/103). Viral suppression at 12 months in the intervention arm was 73.6% (67/91) versus 51.9% (40/77) in the standard of care arm, p=0.01. Retention in care was 88.4% (91/103) in the intervention vs. 74.7% (77/103) in the standard of care arm p=0.01.

conclusionThis is the first study in Uganda to demonstrate that mHealth has the potential to improve medication adherence and retention in care among youth living with HIV in Uganda.

trial registrationNCT04718974 Registry: clinical Trials.gov.

Indexed as

HIV InfectionsMedication AdherenceTelemedicineAdolescentAdultAnti-HIV AgentsAnti-Retroviral AgentsFemaleHumansMaleUgandaViral LoadYoung AdultAnti-HIV AgentsAnti-Retroviral Agents

Identifiers

PMID39561129
PMCPMC11575762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.